Pubblicazioni

Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis

2023 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Facheris, P.; Da Rosa, J. C.; Rothenberg-Lausell, C.; del Duca, E.; David, E.; Estrada, Y.; Liu, Y.; Bose, S.; Chowdhury, M.; Munera, C.; Goncalves, J.; Nograles, K.; Kim, B. S.; Lebwohl, M.

Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020

2021 - CANCER METASTASIS REVIEWS

Giunta, S.

The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults

2021 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Renert-Yuval, Y.; Del Duca, E.; Pavel, A. B.; Fang, M.; Lefferdink, R.; Wu, J.; Diaz, A.; Estrada, Y. D.; Canter, T.; Zhang, N.; Wagner, A.; Chamlin, S.; Krueger, J. G.; Guttman-Yassky, E.; Paller, A. S.

Combined ascorbic acid and T3 produce better healing compared to bone marrow mesenchymal stem cells in an Achilles tendon injury rat model. A proof of concept study

2019 - JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH

Oliva, F.; Maffulli, N.; Gissi, C.; Veronesi, F.; Calciano, L.; Fini, M.; Brogini, S.; Gallorini, M.; Antonetti Lamorgese Passeri, C.; Bernardini, R.; Cicconi, R.; Mattei, M.; Berardi, A. C.

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

2019 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pavel, A. B.; Song, T.; Kim, H. -J.; Del Duca, E.; Krueger, J. G.; Dubin, C.; Peng, X.; Xu, H.; Zhang, N.; Estrada, Y. D.; Denis, L.; Rao, N.; Gupta, S.; Zammit, D. J.; Bissonnette, R.; Guttman-Yassky, E.